病例报告：抗 BCMA CAR-T 细胞治疗成功治愈继发于多发性骨髓瘤的浆细胞白血病 Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy. PubMed 2022/09/21 发表Front OncolQ2 · IF 3.4（JCR 2025） 靶点：CD38靶点：BCMA技术：CAR-T多发性骨髓瘤白血病地区：中国
复发/难治性多发性骨髓瘤患者中人源化抗 BCMA 与鼠源抗 CD38 CAR-T 细胞治疗的联合 A combination of humanized anti-BCMA and murine anti-CD38 CAR-T cell therapy in patients with relapsed or refractory multiple myeloma. PubMed 2022/02/01 发表Leuk LymphomaQ3 · IF 2.1（JCR 2025） 靶点：CD38靶点：BCMA技术：CAR-T多发性骨髓瘤淋巴瘤白血病
肿瘤细胞治疗研究
肿瘤细胞治疗研究